Ramtin Agah - Apr 11, 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Stock symbol
RNXT
Transactions as of
Apr 11, 2025
Transactions value $
$16,000
Form type
4
Date filed
4/14/2025, 06:30 AM
Previous filing
Apr 10, 2025
Next filing
Apr 16, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNXT Common Stock Purchase $16K +20K +1.85% $0.80 1.1M Apr 11, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects open market purchases of the Issuer's securities.